84 related articles for article (PubMed ID: 30726305)
1. Rapid and easy detection of the five most common mutations in BRCA1 and BRCA2 genes in the Polish population using CAPS and ACRS-PCR methods.
Dąbrowski A; Ułaszewski S; Niedźwiecka K
Acta Biochim Pol; 2019 Feb; 66(1):33-37. PubMed ID: 30726305
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
[TBL] [Abstract][Full Text] [Related]
3. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
Kowalik A; Siołek M; Kopczyński J; Krawiec K; Kalisz J; Zięba S; Kozak-Klonowska B; Wypiórkiewicz E; Furmańczyk J; Nowak-Ozimek E; Chłopek M; Macek P; Smok-Kalwat J; Góźdź S
PLoS One; 2018; 13(7):e0201086. PubMed ID: 30040829
[TBL] [Abstract][Full Text] [Related]
5. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.
Szwiec M; Jakubowska A; Górski B; Huzarski T; Tomiczek-Szwiec J; Gronwald J; Dębniak T; Byrski T; Kluźniak W; Wokołorczyk D; Birkenfeld B; Akbari MR; Narod SA; Lubiński J; Cybulski C
Clin Genet; 2015 Mar; 87(3):288-92. PubMed ID: 24528374
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutations in a South American population.
Jara L; Ampuero S; Santibáñez E; Seccia L; Rodríguez J; Bustamante M; Martínez V; Catenaccio A; Lay-Son G; Blanco R; Reyes JM
Cancer Genet Cytogenet; 2006 Apr; 166(1):36-45. PubMed ID: 16616110
[TBL] [Abstract][Full Text] [Related]
7. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
[TBL] [Abstract][Full Text] [Related]
8. Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
Riahi A; Kharrat M; Ghourabi ME; Khomsi F; Gamoudi A; Lariani I; May AE; Rahal K; Chaabouni-Bouhamed H
Clin Genet; 2015 Feb; 87(2):155-60. PubMed ID: 24372583
[TBL] [Abstract][Full Text] [Related]
9. Hereditary ovarian cancer in Poland.
Menkiszak J; Gronwald J; Górski B; Jakubowska A; Huzarski T; Byrski T; Foszczyńska-Kłoda M; Haus O; Janiszewska H; Perkowska M; Brozek I; Grzybowska E; Zientek H; Góźdź S; Kozak-Klonowska B; Urbański K; Miturski R; Kowalczyk J; Pluzańska A; Niepsuj S; Koc J; Szwiec M; Drosik K; Mackiewicz A; Lamperska K; Strózyk E; Godlewski D; Stawicka M; Waśko B; Bebenek M; Rozmiarek A; Rzepka-Górska I; Narod SA; Lubiński J
Int J Cancer; 2003 Oct; 106(6):942-5. PubMed ID: 12918074
[TBL] [Abstract][Full Text] [Related]
10. Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
Cini G; Mezzavilla M; Della Puppa L; Cupelli E; Fornasin A; D'Elia AV; Dolcetti R; Damante G; Bertok S; Miolo G; Maestro R; de Paoli P; Amoroso A; Viel A
BMC Med Genet; 2016 Feb; 17():11. PubMed ID: 26852130
[TBL] [Abstract][Full Text] [Related]
11. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the most frequent BRCA1 mutations in Polish population.
Brozek I; Cybulska C; Ratajska M; Piatkowska M; Kluska A; Balabas A; Dabrowska M; Nowakowska D; Niwinska A; Pamula-Pilat J; Tecza K; Pekala W; Rembowska J; Nowicka K; Mosor M; Januszkiewicz-Lewandowska D; Rachtan J; Grzybowska E; Nowak J; Steffen J; Limon J
J Appl Genet; 2011 Aug; 52(3):325-30. PubMed ID: 21503673
[TBL] [Abstract][Full Text] [Related]
14. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.
Konecny M; Milly M; Zavodna K; Weismanova E; Gregorova J; Mlkva I; Ilencikova D; Kausitz J; Bartosova Z
Breast Cancer Res Treat; 2011 Feb; 126(1):119-30. PubMed ID: 21203900
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers.
Górski B; Debniak T; Jakubowska A; Cybulski C; Huzarski T; Byrski T; Złowocka E; Lubiński J
J Appl Genet; 2003; 44(3):419-23. PubMed ID: 12923317
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.
Trujillano D; Weiss ME; Schneider J; Köster J; Papachristos EB; Saviouk V; Zakharkina T; Nahavandi N; Kovacevic L; Rolfs A
J Mol Diagn; 2015 Mar; 17(2):162-70. PubMed ID: 25556971
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg).
Willems P; Magri V; Cretnik M; Fasano M; Jakubowska A; Levanat S; Lubinski J; Marras E; Musani V; Thierens H; Vandersickel V; Perletti G; Vral A
Int J Oncol; 2009 Apr; 34(4):1005-15. PubMed ID: 19287957
[TBL] [Abstract][Full Text] [Related]
19. Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.
Kang HC; Kim IJ; Park JH; Kwon HJ; Won YJ; Heo SC; Lee SY; Kim KH; Shin Y; Noh DY; Yang DH; Choe KJ; Lee BH; King SB; Park JG
Hum Mutat; 2002 Sep; 20(3):235. PubMed ID: 12204006
[TBL] [Abstract][Full Text] [Related]
20. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain.
Esteban Cardeñosa E; Bolufer Gilabert P; Palanca Suela S; Oltra Soler S; Barragán González E; Velasco Sampedro E; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E;
Breast Cancer Res Treat; 2008 Nov; 112(1):69-73. PubMed ID: 18060494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]